Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.
Clinical trial NCT04317703 · COMPLETED
Trial details
- NCT number
- NCT04317703
- Sponsor
- LG Chem
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2020-09-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.